RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Clearpoint Neuro Stock

Clearpoint Neuro Market capitalization 2024

Clearpoint Neuro Market capitalization

176.17 M USD

Ticker

CLPT

ISIN

US18507C1036

WKN

A2PZ3E

In 2024, Clearpoint Neuro's market cap stood at 176.17 M USD, a 25.75% increase from the 140.1 M USD market cap in the previous year.

The Clearpoint Neuro Market capitalization history

YEARMarket Capitalization (undefined USD)
2023177.31
2022254.23
2021397.62
202087.4
201946.82
201825.31
201724.8
201625.54
201560.35
201464.65
201378.03
201283.48
2011-
2010-
2009-
2008-
2007-
2006-
2005-

Clearpoint Neuro Aktienanalyse

What does Clearpoint Neuro do?

Clearpoint Neuro Inc is a leading company in the medical technology industry that specializes in the development and marketing of advanced medical products and systems. The company was founded in 1998 and is headquartered in Irvine, California. Clearpoint Neuro's primary goal is to provide better care and treatment for patients with neurological disorders. Clearpoint Neuro was originally founded in 1998 under the name MRI Intervention to meet the market demand for innovative navigation systems for minimally invasive brain procedures. The company's initial products included imaging devices used during surgery. Since then, the company has expanded its product portfolio and strengthened its market position by focusing on core tasks in the field of medical technology. In 2011, MRI Intervention rebranded as Clearpoint Neuro to accommodate its growing product portfolio. The company now primarily focuses on the development and marketing of platform technologies for the control of minimally invasive instruments during neurosurgical procedures. Its customers include hospitals and research institutions that specialize in neurological and neuroscience applications. Clearpoint Neuro has built an extremely successful business model that specializes in providing advanced medical technology to benefit patients. The company works closely with leading neurosurgeons and researchers to understand the needs of patients and develop the most advanced technologies aimed at improving patient treatment. Clearpoint Neuro is a B2B (Business to Business) company that sells its products and services to hospitals and research institutions to ensure that its products are used by medical professionals with appropriate education and experience. The company also has a strong presence in the academic world, where it focuses on collaborating with laboratories and universities to advance the latest developments in technology and research. The divisions of Clearpoint Neuro include medical product areas developed from its technology base, which are described in more detail in the following sections. ClearPoint System ClearPoint is an intraoperative MRI system that is available as a core component of neurosurgical intervention platforms. It uses advanced technology for real-time localization and navigation of instruments to perform minimally invasive brain surgeries. It utilizes imaging technologies to enable navigation and coordination during the surgical procedure. ClearPoint Neuro Therapies ClearPoint Neuro Therapies includes three main areas: "DBS," "MRI-Guided Focused Ultrasound," and "Laser Therapy." DBS (Deep Brain Stimulation) is a minimally invasive neural therapy that involves the insertion of thin electrodes into the brain using a specially existing surgical technique to treat degenerative diseases, particularly Parkinson's disease. Another highly innovative therapy option is MRI-Guided Focused Ultrasound therapy, which targets and precisely destroys cancer cells using focused ultrasound waves. ClearPoint Neuro is one of the leading providers of this advanced therapy. Laser therapy involves the destruction of selected neural cells using heat. ClearPoint Neuro Navigation ClearPoint Neuro's navigation technologies are leading in neurosurgery and research. Navigation allows for precise placement of needles in the brain to obtain biopsies under ultrasound guidance or to administer medication targetedly without damaging the brain. The system is used by neurosurgeons and researchers worldwide. In conclusion, Clearpoint Neuro Inc is a leading company in the medical technology industry that specializes in the development and manufacturing of advanced systems and products for neurosurgery and research. The company has built a strong business model by working closely with leading neurosurgeons and researchers and developing the most advanced technologies aimed at improving the quality of patient care. The ClearPoint System, ClearPoint Neuro Therapies, and ClearPoint Neuro Navigation divisions play a significant role in its success. Clearpoint Neuro ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Clearpoint Neuro's Market Capitalization

Clearpoint Neuro's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Clearpoint Neuro's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Clearpoint Neuro's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Clearpoint Neuro’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Clearpoint Neuro stock

What is the current Clearpoint Neuro market capitalization?

The current market capitalization of Clearpoint Neuro is 176.17 M USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Clearpoint Neuro.

How has the market capitalization of Clearpoint Neuro developed in recent years?

The market capitalization of Clearpoint Neuro has increased/decreased by 25.75% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Clearpoint Neuro?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Clearpoint Neuro?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Clearpoint Neuro have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Clearpoint Neuro pay?

Over the past 12 months, Clearpoint Neuro paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Clearpoint Neuro is expected to pay a dividend of 0 USD.

What is the dividend yield of Clearpoint Neuro?

The current dividend yield of Clearpoint Neuro is .

When does Clearpoint Neuro pay dividends?

Clearpoint Neuro pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Clearpoint Neuro?

Clearpoint Neuro paid dividends every year for the past 0 years.

What is the dividend of Clearpoint Neuro?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Clearpoint Neuro located?

Clearpoint Neuro is assigned to the 'Health' sector.

Wann musste ich die Aktien von Clearpoint Neuro kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Clearpoint Neuro from 8/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/1/2024.

When did Clearpoint Neuro pay the last dividend?

The last dividend was paid out on 8/1/2024.

What was the dividend of Clearpoint Neuro in the year 2023?

In the year 2023, Clearpoint Neuro distributed 0 USD as dividends.

In which currency does Clearpoint Neuro pay out the dividend?

The dividends of Clearpoint Neuro are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Clearpoint Neuro

Our stock analysis for Clearpoint Neuro Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Clearpoint Neuro Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.